ETF Preview: ETFs, Futures Mixed as Investors Look Ahead to Yellen's Speech on Tuesday


Active broad-market exchange-traded funds at the close of Friday's regular session:

SPDR S&P 500 ( SPY ): +1.24%

iShares S&P 500 ( IVV ): +1.31%

PowerShares QQQ ( QQQ ): +1.78%

iShares Russell 2000 ( IWM ): +1.13%

iShares Russell 1000 Growth ( IWF ): -0.30%

iShares MSCI Emerging Markets Index (EEM): +0.57%

United States Oil Fund (USO): +2.12%

SPDR Gold Shares (GLD): +0.77%

Select Financial Sector SPDRS (XLF): -0.10%

Pre-Market Movers

SPY, -0.10%

EEM, -0.36%

IWM, -0.03%

XLF, +0.05%

GDX, +1.42%

Broad Market Indicators

Most broad-market exchange-traded funds, including SPY, IWM, IVV are mixed. Actively traded PowerShares QQQ ( QQQ ) was up 0.03%.

U.S. futures are also mixed in light pre-market trading, with no economic data releases on tap. Investors will be awaiting new Federal Reserve Chief Janet Yellen's testimony before the House Financial Services Committee Tuesday. In earnings news, Hasbro (HAS), (SOHU) and Dick's Sporting Goods (DKS) are among early gainers.

Power Play: Consumer

Consumer Staples Select Sector SPDR (XLP), Vanguard Consumer Staples ETF (VDC) and iShares Dow Jones US Consumer Goods (IYK) were unchanged pre-market after a firmer session Friday.

In stocks news, Hasbro, Inc. (HAS) was down more than 2% after reporting adjusted diluted EPS for Q4 2013 of $1.12 versus $1.20 last year. The Street was looking for diluted EPS of $1.24, according to Capital IQ. Revenues were flat at $1.28 billion compared to last year and in line with the Capital IQ consensus. Furthermore, the company set a quarterly cash dividend of $0.43 per common share, up 8% from the previous quarterly dividend paid. The current dividend will be distributed on May 15 to shareholders of record at the close of business on May 1.

Winners and Losers


Select Financial Sector SPDRs (XLF) was leaning into positive territory pre-bell. Direxion Daily Financial Bull 3X shares (FAS) gained 0.8%. Its bearish counterpart, FAZ, fell 0.18%.

Among financial stocks, Barclays (BCS) was up more than 1% in Monday's pre-bell session despite a news story that broke over the weekend saying the bank had suffered a data leak in which thousands of its customer details were stolen and sold to brokers. Barclays also said this morning that it earned adjusted pretax profit of GBP5.2 billion in 2013, below estimates for GBP5.4 billion. It will release its full results tomorrow morning.


Technology Select Sector SPDR ETF (XLK), iShares Dow Jones US Technology ETF (IYW), iShares S&P North American Technology ETF (IGM) and iShares S&P North American Technology-Software Index (IGV) were firmer. SPDR S&P International Technology Sector ETF (IPK) all closed higher on Friday, but were unchanged pre-market.

Among semiconductor ETFs, SPDR S&P Semiconductor (XSD) and Semiconductor Sector Index Fund (SOXX) were also flat after posting gains Friday.

In stocks news, AutoNavi (AMAP) was up 29% in Monday's pre-market after Alibaba offered to take the company private for $21 per ADS.


Dow Jones U.S. Energy Fund (IYE) was flat, and Energy Select Sector SPDR (XLE) slipped 0.05%.

In corporate news, Gran Tierra Energy Inc. (GTE, GTE.TO) said that after producing a record volume of oil last year, its oil reserves grew at year-end 2013 in all categories. It said total proved oil and gas reserves net after royalty increased 4% year over year to 42.1 million barrels of oil equivalent (MMBOE). Total Proved plus Probable reserves net after royalty were up 99% to 111.9 MMBOE from last year. Total Proved plus Probable plus Possible reserves net after royalty jumped 113% to 183.9 MMBOE.


Crude fell 0.32%; United States Oil Fund (USO) flat. Natural gas fell 1.74% and United States Natural Gas Fund (UNG) dropped 1.86%.

Gold rose 1.05% and silver fell 1.60%. Among rare metal funds, SPDR Gold Trust (GLD) rose 0.74% and iShares Silver Trust (SLV) edged up 1.30%.


Health Care SPDR (XLV), Vanguard Health Care ETF (VHT) and iShares Dow Jones US Healthcare (IYH) were all flat after gaining on Friday. Biotech ETF iShares NASDAQ Biotechnology Index (IBB) was slipping into the red, pre-bell.

In corporate news, Regeneron Pharmaceuticals (REGN) and Bayer Healthcare said data from its Phase 3 trial on the Eylea drug to treat diabetic macular edema showed a sustained improvement at week 100. The drug was well tolerated. Regeneron has the exclusive rights to the drug in the U.S.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities

Referenced Stocks: SPY , IVV , QQQ , IWM , IWF

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos



Most Active by Volume

  • $10.24 ▲ 33.16%
  • $27.29 ▲ 1.75%
    $15.69 unch
  • $10.98 ▲ 5.48%
  • $11.83 ▲ 5.81%
  • $18.22 ▲ 3.70%
  • $111.31 ▲ 0.48%
  • $5.16 ▲ 5.52%
As of 10/6/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by